Laguna Pharmaceuticals, formerly known as ChanRx, is a biopharmaceutical company advancing vanoxerine for treatment of atrial fibrillation and atrial flutter.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 02/17/15 | $30,000,000 | Series B |
BioMed Ventures Frazier Healthcare Versant Ventures | undisclosed |
